DHRS4 and non-small cell lung carcinoma: Moreover, DHRS4-AS1 markedly downregulated the expression of OCT4, SOX2, CD34, and CD133, which were reported as NSCLC stemness markers (Heng et al., 2019) (Figures 2F,G and Supplementary File).